Neurobiological Technologies Price on January 30, 2023
NTIIDelisted Stock | USD 0.0001 0.00 0.00% |
If you're considering investing in Neurobiological Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neurobiological Technologies stands at 0.0001, as last reported on the 30th of December, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. We have found three technical indicators for Neurobiological Technologies, which you can use to evaluate the volatility of the firm.
Neurobiological Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Neurobiological |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
NTII |
Based on monthly moving average Neurobiological Technologies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neurobiological Technologies by adding Neurobiological Technologies to a well-diversified portfolio.
Neurobiological Technologies Valuation on January 30, 2023
It is possible to determine the worth of Neurobiological Technologies on a given historical date. On January 30, 2023 Neurobiological was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Neurobiological Technologies stock. Still, in general, we apply an absolute valuation method to find Neurobiological Technologies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neurobiological Technologies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Neurobiological Technologies' related companies.
Open | High | Low | Close | Volume | |
0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/30/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
Backtest Neurobiological Technologies | | | Neurobiological Technologies History | | | Neurobiological Technologies Valuation | Previous | Next |
Neurobiological Technologies Trading Date Momentum on January 30, 2023
On January 31 2023 Neurobiological Technologies was traded for 0.0001 at the closing time. The top price for the day was 0.0001 and the lowest listed price was 0.0001 . There was no trading activity during the period 1.0. Lack of trading volume on January 31, 2023 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
Neurobiological Technologies Fundamentals Correlations and Trends
By evaluating Neurobiological Technologies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Neurobiological Technologies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Neurobiological financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Neurobiological Technologies Stock history
Neurobiological Technologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neurobiological is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neurobiological Technologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neurobiological Technologies stock prices may prove useful in developing a viable investing in Neurobiological Technologies
Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. The company was founded in 1987 and is based in Emeryville, California. Neurobiological Technologies operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Neurobiological Technologies Stock Technical Analysis
Neurobiological Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Neurobiological Technologies Period Price Range
Low | December 30, 2024
| High |
0.00 | 0.00 |
Neurobiological Technologies cannot be verified against its exchange. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Neurobiological Technologies December 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Neurobiological Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neurobiological Technologies shares will generate the highest return on investment. By undertsting and applying Neurobiological Technologies stock market strength indicators, traders can identify Neurobiological Technologies entry and exit signals to maximize returns
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Neurobiological Stock
If you are still planning to invest in Neurobiological Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobiological Technologies' history and understand the potential risks before investing.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |